(Q33279942)

25 July 2017

The RANKL inhibitor OPG-Fc increases cortical and trabecular bone mass in young gonad-intact cynomolgus monkeys (English)

1 reference

25 July 2017

Ominsky MS

1

1 reference

25 July 2017

Kostenuik PJ

2

1 reference

25 July 2017

Cranmer P

3

1 reference

25 July 2017

Smith SY

4

1 reference

25 July 2017

Atkinson JE

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

24 March 2007

1 reference

Osteoporosis International

25 July 2017

1 reference

25 July 2017

18

1 reference

25 July 2017

8

1 reference

25 July 2017

1073-1082

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-007-0363-7

25 July 2017

0 references

cites work

Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-007-0363-7

Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption

21 January 2018

1 reference

12 December 2020

Mechanical validation of a tomographic (pQCT) index for noninvasive estimation of rat femur bending strength

1 reference

12 December 2020

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

1 reference

12 December 2020

Nonhuman primate models in skeletal research

1 reference

12 December 2020

OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats

1 reference

12 December 2020

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

12 December 2020

Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading

1 reference

12 December 2020

The effect of a single dose of osteoprotegerin in postmenopausal women

1 reference

12 December 2020

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

1 reference

12 December 2020

RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis

1 reference

12 December 2020

Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.

1 reference

12 December 2020

Geometric variables from DXA of the radius predict forearm fracture load in vitro.

1 reference

12 December 2020

Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis

1 reference

12 December 2020

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

1 reference

12 December 2020

Osteoprotegerin mitigates tail suspension-induced osteopenia

1 reference

12 December 2020

Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis

1 reference

12 December 2020

The effects of osteoprotegerin on the mechanical properties of rat bone

1 reference

12 December 2020

A toxicity profile of osteoprotegerin in the cynomolgus monkey

1 reference

12 December 2020

Correlation of bone mineral density with strength and microstructural parameters of cortical bone in vitro.

1 reference

12 December 2020

Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats.

1 reference

12 December 2020

10.1007/S00198-007-0363-7

Identifiers

DOI

1 reference

release_2dkov5wzgrgezchnsijfmpdlq4

25 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2dkov5wzgrgezchnsijfmpdlq4

24 November 2022

mapped directly with Wikidata item

1 reference